InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,694.18
(
-0.34%
)
US TECH 100
19,224.40
(
-0.57%
)
Dow Jones
41,960.71
(
-0.15%
)
Brent Oil
73.88
(
-0.59%
)
Bitcoin
63,186.30
(
0.38%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BlueRayn

Send PM Follow Ignore
Followers 118
Posts 6733
Boards Moderated 0
Alias Born 08/24/2013

BlueRayn

Re: None

Tuesday, 01/23/2018 1:02:48 PM

Tuesday, January 23, 2018 1:02:48 PM

Post# of 438
Bottom line is Galliprant is giving dogs a new lease on quality of life. Google Galliprant reviews. 75% re-order rate. Over $20Mil in milestones coming in 2018. Undervalued imo.

https://seekingalpha.com/article/4139298-aratana-therapeutics-investors-barking-wrong-tree

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up